Literature DB >> 3259240

Assessment of [11C]-L-methionine transport into the human brain.

L A O'Tuama1, T R Guilarte, K H Douglass, H N Wagner, D F Wong, R F Dannals, H T Ravert, A A Wilson, N D LaFrance, A N Bice.   

Abstract

Neutral amino acid transport into human brain was measured using a dual-probe positron detection system or positron emission tomography (PET). Rate constants (ml/min/cc) for brain accumulation of [11C]L-methionine measured with the dual detector ranged from 0.012 to 0.078 (average 0.031) under baseline conditions and from 0.010 to 0.017 (average 0.014) after administration of nonradioactive L-phenylalanine (100 mg/kg). The net rate of brain accumulation of L-methionine ranged from 0.42 to 2.89 (average 1.28) nmol/min/cc, and decreased by 27.5-91.2% (average 53.9%) after L-phenylalanine. PET-estimated accumulation rates (ml/min/cc) of [11C]L-methionine ranged from 0.004 to 0.028 (average 0.016) baseline and from 0.010 to 0.021 (average 0.017) after L-phenylalanine. Initial volumes of distribution (ml/cc) of [11C]L-methionine (dual detector) were 0.044-0.070 (average 0.058) baseline and 0.032-0.074 (average 0.051) after phenylalanine and (PET) 0.026-0.098 (average 0.051) baseline and 0.021-0.061 (average 0.042) after phenylalanine. PET permits more accurate measurement of tracer accumulation by brain, excluding noncerebral regions included in dual-detector measurements. The dual-detector system permits better temporal resolution, facilitating kinetic analysis, and requires only one-fortieth the dose of tracer needed for PET. Multiple studies in the same patient are thus possible at low cost.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259240     DOI: 10.1038/jcbfm.1988.69

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  3 in total

1.  Metabolic fate of L-[methyl-11C]methionine in human plasma.

Authors:  K Ishiwata; J Hatazawa; K Kubota; M Kameyama; M Itoh; T Matsuzawa; T Takahashi; R Iwata; T Ido
Journal:  Eur J Nucl Med       Date:  1989

2.  Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.

Authors:  S Mitsuki; M Diksic; T Conway; Y L Yamamoto; J G Villemure; W Feindel
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

3.  Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.

Authors:  Alexander Becherer; Georgios Karanikas; Monica Szabó; Georg Zettinig; Susanne Asenbaum; Christine Marosi; Christine Henk; Patrick Wunderbaldinger; Thomas Czech; Wolfgang Wadsak; Kurt Kletter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-23       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.